Next Article in Journal
Factors Influencing Men’s Attitudes toward HPV Vaccination in Males Included in the Chinese National Immunization Program
Next Article in Special Issue
Side Effects of COVID-19 Vaccines in Pregnant and Lactating Mexican Women and Breastfed Infants: A Survey-Based Study
Previous Article in Journal
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Correlates of Zero-Dose Vaccination Status among Children Aged 12–59 Months in Sub-Saharan Africa: A Multilevel Analysis of Individual and Contextual Factors

1
Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA
2
South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA
3
Big Data Health Science Center (BDHSC), University of South Carolina, Columbia, SC 29208, USA
4
Geoinformation and Big Data Research Laboratory, University of South Carolina, Columbia, SC 29208, USA
5
Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA
*
Author to whom correspondence should be addressed.
Vaccines 2022, 10(7), 1052; https://doi.org/10.3390/vaccines10071052
Submission received: 7 June 2022 / Revised: 24 June 2022 / Accepted: 27 June 2022 / Published: 30 June 2022
(This article belongs to the Special Issue Immunization of Children and Women against Infectious Diseases)

Abstract

:
Despite ongoing efforts to improve childhood vaccination coverage, including in hard-to-reach and hard-to-vaccinate communities, many children in sub-Saharan Africa (SSA) remain unvaccinated. Considering recent goals set by the Immunization Agenda 2030 (IA2030), including reducing the number of zero-dose children by half, research that goes beyond coverage to identify populations and groups at greater risk of being unvaccinated is urgently needed. This is a pooled cross-sectional study of individual- and country-level data obtained from Demographic and Health Surveys Program and two open data repositories. The sample includes 43,131 children aged 12–59 months sampled between 2010 and 2020 in 33 SSA countries. Associations of zero-dose status with individual and contextual factors were assessed using multilevel logistic regression. 16.5% of children had not received any vaccines. Individual level factors associated lower odds of zero-dose status included mother’s primary school or high school education, employment, use of antenatal care services and household wealth. Compared to children in countries with lower GDP, children in countries with relatively high GDP had nearly four times greater odds of being unvaccinated. Both individual and contextual factors are correlated with zero-dose status in SSA. Our results can inform efforts to identify and reach children who have not received any vaccines.

1. Introduction

Vaccine discovery and mass distribution through the Expanded Program on Immunization (EPI) established in 1974, remains one of the greatest public health achievements in reducing morbidity and mortality among children globally [1,2,3]. Since EPI debut, many under-five children in low-and-middle income countries (LMICs) have been saved from catastrophic diseases such as Polio, Measles, Diphtheria, Tetanus, Pertussis and Tuberculosis [4,5,6,7,8]. The use of vaccines prevents over 2.5 million deaths each year in under-five children [9,10]. Despite this progress, 1 in 5 children in SSA lack access to necessary life-saving vaccines [11]. As a result, more than 30 million African children under age 5 are affected by vaccine-preventable diseases and, of those, more than 500,000 die each year [12].
Because of these benefits, governments, and international organizations have developed innovative strategies to improve vaccination coverage and penetration into hard-to-reach areas. These strategies include, Reaching Every District (RED) approach, Global Immunization Vision and Strategy (GIVS), and the Global Vaccine Action Plan (GVAP) [13,14,15]. Apart from these strategies, over USD 112 billion funding was provided for vaccine coverage between 2000 and 2017 [16]. However, the focus on “coverage” misses a potentially important population: children with zero-dose vaccination status.
World Health Organization (WHO) and United Nations Children’s Fund (UNICEF) estimates show that 14 million and 17 million zero-dose children exist between 2019 and 2020, respectively, and they mainly reside in 10 lower middle-income countries (LMICs) [17,18,19]. This report indicates that the number of children who should have received the required immunization during the eligibility period (i.e., before their first birthday) and the formative years that follow, is growing [17,18,19]. Inability to reach the zero-dose children could be a pointer to why achieving the 90% goal of vaccine coverage at country and regional level remains a hurdle in SSA to date [20].
To ensure that no child is left behind, the World Health Assembly set an ambitious target of reducing the number of zero-dose children by 50% through the Immunization Agenda 2030 (IA2030) [21]. This is also embodied in the Sustainable Development Goals (SDGs) target 3.2, aimed at ending preventable deaths of newborns and under-five children by 2030 [22]. Achieving the goals outlined in both IA2030 and SDGs requires sufficient research and attention particularly directed to the zero-dose children.
Children with zero-dose vaccination status are at increased risk for infections with vaccine preventable diseases (VPDs) such as measles, polio, and pneumonia, during the first 5 years of life [23]. They are also part of the world’s most vulnerable population, more likely to suffer from disability and mortality that could easily be prevented through immunization [24,25,26]. These children are predominantly less privileged, live in rural households, and raised by mothers with little or no education, indicating disparity within countries [27,28,29]. Lack of attention to the zero-dose population may pose a public health threat in the future, leading to re-emergence of eradicated diseases such as polio, and/or potential disease outbreak such as measles.
While many studies have enumerated factors that impact vaccination coverage, uptake, timeliness, and drop-out rates among specific or different immunization in SSA; how these factors affect the zero-dose population have not been comprehensively examined since most studies are country, facility or intervention-specific, limiting their generalizability [4,5,7,8,9]. For example, while a recent study examined correlates of never-vaccinated children in Nigeria, [23] it is not clear how the results could be generalized in other African countries given the vastly different context across countries in SSA. Similarly, a multi-country study shows that unvaccinated children remain undetected and/or underreported by routine monitoring [30]. This study broadly reported on LMICs without accounting for nuances in Africa. A comprehensive multinational study with primary focus in SSA is needed to fill these gaps. Arambepola et al., reported that incomplete knowledge on factors influencing zero-dose children in SSA needs to be properly investigated [25]. Given the growing concern of changing the status of children from zero-dose to fully vaccinated is yet to be addressed, more studies are needed to identify factors affecting zero-dose children [24,31].
The objective of this study is to identify populations and groups of children at greater risk of being unvaccinated (zero-dose). Considering the high under-five mortality rate in SSA and reports that immunization coverage has plateaued in recent years, we hypothesized that the prevalence of children with zero-dose vaccination status would be high. We also hypothesized that both individual and contextual factors play a role in whether or not a child has been vaccinated. In testing this hypothesis, this study aims to define the prevalence of children with zero-dose vaccination status and examine the independent associations of individual and contextual factors with zero-dose vaccination status among children aged 12–59 months in SSA. Our results can inform efforts to identify and reach children who have not received any vaccines.

2. Materials and Methods

2.1. Data Sources

We obtained individual and household-level data from the Demographic and Health Survey (DHS) program [32]. The DHS program started over 35 years ago, with over 400 surveys conducted in over 90 countries since inception [33,34]. The DHS data are nationally representative, cross-sectional, household surveys typically conducted every 5 years to track progress related to national development targets at various levels [34]. The DHS surveys are conducted using standard approach designed to allow for comparison between countries or regions [33]. Detailed information is collected on diverse areas including childhood immunization, infant and child mortality, maternal and child health, reproductive health, Malaria, HIV/AIDS and family planning among others [35]. The DHS program uses a stratified two-stage cluster probabilistic sampling design, with response rates typically exceeding 90% [36]. The first stage involves selection of the primary sampling units (PSUs) called the Enumeration Areas (EA) drawn from census files with the probability of selecting a unit proportional to its size within each stratum [33]. In the second stage, a sample of household is drawn from an updated list of households by equal probability systematic sampling in each EA selected [33]. Details about the DHS program and sampling design has been published elsewhere [35]. We selected countries in SSA with a standard DHS conducted between 2010–2020 for the study (i.e., survey conducted within the last 10 years). This yielded a total of 33 eligible countries (Table 1).
We also obtained country-level data from reports published by the World bank: GDP per capita, literacy rate, fertility rate, health expenditure, unemployment rate, physician density, [37] and the Institute for Economics and Peace (IEP): Global Peace Index (GPI), [38] using each country’s most recent available data consistent or closely related to the DHS survey year.

2.2. Study Design and Sample Size

This study was a secondary data analysis of existing data on childhood immunization and utilized a pooled cross-sectional study design. Approximately 44,800 children whose mothers are within the reproductive age group (15–49 years) were initially sampled. Our analysis sample includes 43,131 children whose mother had no missing information on vaccination status and important demographic characteristics.

2.3. Measures

2.3.1. Outcome Variable

Our outcome variable was an indicator for a child’s zero-dose vaccination status. We created a binary variable that was equal to 1 if a child had not yet received any childhood vaccine indicated for children between the ages of 12–59 months. To assess this outcome, the interviewer asked mothers two questions. First, “can they present child immunization card that contain the vaccination history?” This initial step was taken to minimize recall bias. Mothers who could not present an immunization card were asked the child specific follow-up question–“ever had any vaccination?”.
Children of mothers who could present child immunization card (reflected in the card to have participated in no episode of vaccination) and of mothers who were not in possession of immunization card and who responded “no” to the child specific follow-up question were categorized ‘zero-dose’ and were coded “1”. Mothers who could present child immunization card (reflected in the card to have participated in at least one episode of vaccination) and responded “yes” to the follow-up question were categorized “vaccinated” and were coded “0”.

2.3.2. Explanatory Variables

The selection of explanatory variables was guided by the literature and data availability and were grouped into two categories: individual factors and contextual factors. Contextual factors were further divided into those collected in the DHS surveys and measured at the household level and those collected from other publicly available data sources and measured at the national level.

Individual Factors

Individual factors included child’s sex (male [ref group] or female), child’s age measured in months (12–24 [ref group], 24–36, 37–48, or 49–59),birth order (1 [ref group], 2–3, 4–5, or 6+), birth weight (low, normal, high, or not weighed [ref group]),mother’s age measured in years (15–19 [ref group], 20–24, 25–34, 35–39, 40–44, or 45–49), mother’s marital status (single/widowed [ref group] or married/cohabitating), mother’s education (no education [ref group], primary school, incomplete high school, or completed high school), mother’s occupation (unemployed [ref group] or employed), antenatal care utilization (no visit [ref group], <4 visits, ≥4 visits, or not asked), place of delivery (home [ref group], public hospital, private hospital, or other location), and exposure to mass media (no TV/radio [ref group] or TV/radio).

Contextual Factors

Contextual factors collected in the DHS surveys and measured at the household level included place of residence (urban [ref group] or rural), household wealth index quintile (poorest [ref group], poorer, middle, richer, or richest), and religion (Christian [ref group], Muslim, other religion, no religion, or not asked). Contextual factors measured at the national level included GDP per capita, domestic general government health expenditure (as a percentage of general government expenditure), adult female literacy rate, female unemployment rate, fertility rate, physicians per 1000 people, and Global Peace Index (GPI) overall score. The GPI is a composite index measuring the peacefulness of countries. It is made up of 23 quantitative and qualitative indicators each weighted on a scale of 1–5. The lower the score the more peaceful the country [38]. For government health expenditures, literacy rate, unemployment rate, and fertility rate, we categorized countries into two groups (low [ref group] or high) relative to the median value to provide results that were more easily interpretable. For GDP per capita, physician density, and the GPI, we assigned countries to tertiles (low [ref group], moderate, high) to allow for nonlinear effects. We also included indicators for subregions of Africa defined by the United Nations (Western Africa [ref group], Eastern Africa, Middle Africa, or Southern Africa).

2.3.3. Control Variable

Given the differential timing of DHS surveys across sample countries, we included birth year as a partial control for common trends over the sample period and to adjust for effects of unobserved temporal factors.

2.4. Data Analysis

We applied the method suggested by the DHS to de-normalize the weights for each of the countries, [39] using the United Nations population of women between the ages of 15–49 years (i.e., women of reproductive age) corresponding to the year of survey [40]. Weighted descriptive statistics were performed to summarize the data. We examined the association between zero-dose vaccination status and all explanatory variables. Statistical differences across groups were examined using chi-squared test.
A 2-level multilevel logistic regression analysis was performed to account for the hierarchical nature of the data: individual observations (level one) were nested within countries (level two). Five mixed effect models were fitted as follows: Model 0 (null model, no variables); Model 1: (individual factors); Model 2 (contextual factors measured at the household level); Model 3 (contextual factors measured at the national level), and Model 4 (full model, all individual and contextual factors). Model 1–Model 4 also included birth year as a control variable. We evaluated variance inflation factors (VIFs) to assess multicollinearity among the explanatory variables. A value exceeding 10 was used as the cut-off point [41]. No multicollinearity among the explanatory variables were observed (mean VIF = 1.41, range = 1.0–2.54). We reported both fixed effects (measures of association) and random effects (measures of variation). Fixed effects were summarized using adjusted odds ratios (aORs), with associated 95% confidence intervals (CIs), whereas random effects were assessed by the Intra-class correlation (ICC), median odds ratio (MOR), and proportional change in variance (PCV) [42,43,44,45,46]. We used the Bayesian Information Criterion (BIC) and Akaike Information Criterion (AIC) to assess goodness-of-fit of models. The model with the lowest value was considered the best explanatory model. For variables with 2.5% missingness (religion and antenatal care), the missing values were recoded and included as a separate category in the analysis. In alternative specifications, we removed religion and antenatal care from the full model, respectively. However, our results were not sensitive to these modifications and were qualitatively comparable. We further removed both variables concurrently in the full model, and our results remained unchanged. To ensure representativeness of the sample, the sampling weights were applied to the models. A p-value less than 0.05 was deemed statistically significant. All statistical analyses were performed using Stata Statistical Software, version 15.1, College Station, TX, USA StataCorp LLC.

3. Results

3.1. Descriptive Statistics and Bivariate Analysis

Table 2 and Table 3 present baseline characteristics and bivariate analyses of individual and contextual factors, respectively, in a weighted sample of 43,131 children aged 12–59 months in SSA. 16.5% of children were zero-dose, i.e., had not received any vaccines.

3.1.1. Individual Factors

Among children, roughly one-half were male (50.7%) and one-quarter were older than 36 months (13.2% aged 37–48 months and 12.4% aged 49–59 months). Among mothers, roughly one-quarter were under age 25 (4.4% aged 15–19 years and 21% aged 20–24 years), one-half were between the ages of 25 and 34 (50.5%), and one-quarter were over age 35 (14.9% aged 35–39 years, 7.0% 40–44 years, and 2.2% 45–49 years). Nearly all mothers were married or cohabitating (90.1%), and the vast majority reported no secondary level education (47.6% no formal schooling and 30.8% primary school only). More than 50% of mothers were employed (56.7%). Nearly one-half of children were born at home (48.6%). The second most common place of birth was public hospital (40.3%). More than 60% of mothers reported that their child had not been weighed at birth (60.5%). Compared to children whose birth weight was recorded, children who were not weighed were significantly more likely to be zero-dose (25% versus 9.1%, 5.3%, and 6.0% for low, normal and high birth weight, respectively). While risk of zero-dose status diminished with age, nearly one-tenth of children older than 36 months remained unvaccinated (9.8% and 9.4% of children aged 37–48 months and 49–59 months, respectively). By comparison, 20.1% of children aged 12–24 months and 17.8% of children aged 15–36 months were unvaccinated. Children born to mothers who had no formal education (23.7% versus 12.4% and 5.49% for completed primary and secondary education, respectively), who were unemployed (21.1% versus 13.0%), who did not receive any antenatal care (35.9% versus 13.3% and 8.97% for 1–4 or 4+ visits, respectively) were significantly more likely to be zero-dose. Risk of zero-dose status was strongly associated with place of delivery. Compared to children born in a health facility, children born at home or in other locations were significantly more likely to be unvaccinated (24.6% and 28% versus 7.76% and 6.34% for those born in public and private hospitals, respectively). Compared to those with regular exposure to media, mothers with no TV/radio were significantly more likely to have zero-dose children (20.2% versus 12.7%).

3.1.2. Contextual Factors

A majority of children resided in rural locations (75.0%) and in countries with low GDP per capita (54.7%), low government health expenditure (54.7%), low adult female literacy rate (61.3%), low female unemployment rate (70.8%), and high fertility rate (59.8%). Most resided in countries with a moderate or high overall GPI scores (39.6% moderate and 44.5% high). Nearly one-half of children belonged to households in the lowest two wealth index quintiles (26.3% poorest category and 23.1% poorer category). Over one-half of mothers were Christian (55.4%). Nearly one-third of mothers were Muslim (31.6%). Compared to those residing in urban areas, children in rural areas were much more likely to be zero-dose (19.1% versus 8.67%). Risk of zero-dose status diminished with household wealth. Roughly one-fifth of children in the lowest two wealth index quintiles were unvaccinated (23.5% and 20.3% of children in the poorest and poorer households, respectively). By comparison, 14.8% of children in the middle quintile, 10.4% of children in the richer quintile, and 6.59% of children in the richest quintile were zero-dose. Muslim children were significantly more likely to be zero-dose than Christian children (25.2% versus 12.3%). Compared to children residing in less wealthy countries, children residing in countries with high GDP per capita were more likely to be unvaccinated (20.4% versus 15.2% and 15.3% for countries with low and moderate GDP per capita, respectively). Children residing in countries with a low adult female literacy rate (21.9% versus 7.94%) and in the Western Africa and Eastern Africa subregions (18.2% and 20% versus 11.4% and 8.6% for the Middle Africa and Southern Africa subregions, respectively) were significantly more likely to be zero-dose.

3.2. Measures of Association (Fixed Effects)

To summarize, in Model 1 (individual factors), child’s age, birth order, birth weight, mother’s education, mother’s occupation, number of antenatal care visits, place of delivery, and exposure to media, were statistically significant predictors of zero-dose status. In Model 2 (contextual factors measured at the household level), rural residence, wealth index quintile, and religion were statistically significant predictors of zero-dose status. In Model 3 (contextual factors measured at the national level), GDP per capita, female unemployment rate, fertility rate and Global Peace Index were the only factors found to be statistically significant. In Model 4 (full model), nearly all individual factors (excluding place of delivery and exposure to mass media) remained statistically significant. Just two contextual factors, household wealth index quintile and national GDP per capita remained statistically significant. Results from Model 4, our preferred specification, are summarized in Figure 1 (individual factors) and Figure 2 (contextual factors) and discussed in greater detail below.

3.2.1. Individual Factors

Children between the ages of 25–36 months were less likely to be zero-dose (aOR: 0.86, 95% CI: 0.76–0.96) compared to children between 12–24 months of age. Compared to first born children, later (fourth or fifth) born children were less likely to be zero-dose (aOR: 0.86, 95% CI: 0.76–0.96). Children with normal birth weight were less likely to be zero-dose (aOR: 0.54, 95% CI: 0.41–0.70) compared to children who were not weighed at birth. The odds of having zero-dose children reduces as mother’s educational attainment increases, such that mothers who completed high school were 49% less likely to have zero-dose children compared to mothers with no education (aOR: 0.51, 95% CI: 0.36–0.71). Similarly, mothers who are employed were 21% less likely to have zero-dose children (aOR: 0.79, 95% CI: 0.71–0.88) compared to mothers who were unemployed. Mothers who received antenatal care were less likely to have zero-dose children, compared to mothers with no antenatal visit, less than four antenatal visits (aOR:0.47, 95% CI 0.32–0.67) and four or more antenatal visits (aOR: 0.36, 95% CI: 0.29–0.45).

3.2.2. Contextual Factors

Compared to children from the poorest households, children from rich households, children from households in the richer (aOR: 0.68, 95% CI: 0.49–0.93), and richest (aOR: 0.67, 95% CI: 0.56–0.80) wealth index quintiles were less likely to be zero-dose. Countries with high GDP per capita were four times more likely to have zero-dose children compared to countries with low GDP per capita (aOR: 3.99, 95% CI: 1.27–12.48).

3.3. Measures of Variation (Random Effects)

As shown in the null model (Model 0, Table S1), there was a significant variation in zero-dose children across the 33 countries (σ2 = 0.79, 95% CI = 0.52–1.20). The ICC coefficient showed low to moderate correlation of zero-dose children within countries (ICC: 19% CI: 14–27%) [47]. The MOR of 2.33 in the null model implied that significant heterogeneity exists across countries. This means that if a child is born in a country with high proportion of zero-dose children, the median risk of being zero-dose would be 2.33 times greater odds. In the full model (Model 4, Table S1), inclusion of the control variable, individual, and contextual factors further reduced the variability within countries (ICC: 5% CI: 4–13%).
Additionally, the full model showed that unexplained heterogeneity in zero-dose children among the countries decreased from MOR of 2.33 to 1.62. However, there is residual variability of likelihood of being zero-dose at the country level. This implies that if a child is born in a country with high proportion of zero-dose children, the median risk of not being vaccinated would have 1.62 greater odds. Variations in zero-dose children across countries were mostly explained by country-level variables (PCV = 68.35%), followed by individual-level variables (PCV = 34.18%), and household-level variables (PCV = 15.19%).

4. Discussion

This multi-country study estimated the prevalence of zero-dose vaccination status and examined the individual and contextual factors associated with zero-dose vaccination status among children aged 12–59 months. Child’s age, birth order, birth weight, mother’s education, mother’s occupation, and number of antenatal care visits were found to be associated with zero-dose vaccination status. Additionally, children from rich households were less likely to be zero-dose than their counterparts from poor households. Countries with high GDP per capita were four times more likely to have zero-dose children compared to countries with low GDP per capita.
The study findings support our hypothesis of high prevalence of zero-dose children in SSA, with approximately 17% children identified with zero-dose status. To the best of our knowledge, this is the first study to estimate the prevalence of children with zero-dose vaccination status, using nationally representative surveys of 33 countries in SSA. Our study mirrors the result of Bosch-Capblanch et al., who reported prevalence of 9.9% of zero-dose children aged 12–59 months in LMICs [25]. Therefore, the current study underscores the need to increase efforts to move the zero-dose status children to fully vaccinated status in SSA.
Between 1980 and 2010, there was a significant decrease in the number of unimmunized children in SSA, most of which were achieved through the GAVI initiative [48,49,50,51]. In 2019, the Global Burden of Disease (GBD) reported that the majority of zero-dose children are in LMICs [27]. With the IA2030 agenda to vaccinate all children, the Vaccine Alliance launched a global movement to reach these communities and help give zero-dose children a healthy and successful future [51]. To sustain the progress made on early child vaccination, a massive vaccination for all children will be required across the globe, particularly in SSA, where zero-dose children exist the most [26].
Early childhood immunization in SSA is considerably low [52]. Studies have reported that approximately 17 million children in LMIC are yet to receive a single dose vaccines [18,26,28]. The majority of these unvaccinated children live in the inner communities of SSA countries that are difficult to access by healthcare workers [53]. In 2020, as a result of the COVID-19 pandemic, most LMICs faced several challenges in basic healthcare services without exceptions to childhood immunization [25]. Therefore, the number of zero-dose children is expected to double as a result of the COVID-19 pandemic [54]. Apart from COVID-19 pandemic, insurgency, conflicts, and war affects childhood immunization [55,56]. Consequently, these communities are likely to suffer from impending factors such as extreme poverty, gender inequality and lack of social amenities as indicators to influence childhood vaccination coverage. Surprisingly, our study did not find an association between conflict, safety, and peace index of a country to be associated with zero-dose children.
Other factors that influence zero-dose vaccination include but are not limited to inequality among countries, population size, lack of vaccination services, attitude of healthcare workers toward mothers, maternal education, vaccine hesitancy and political instability [27,31,52,54,57]. Socioeconomic factors as well as perception of the risk of vaccination also pose a huge threat to early childhood vaccination [26,58,59].
The current study further confirms our second hypothesis that both individual and contextual factors play a role in zero-dose children in SSA. For example, mothers who received antenatal care were less likely to have zero-dose children, compared to mothers with no antenatal visit. This holds true in previous studies [60,61,62]. Prior studies have shown that mother’s age and mother’s level of education can influence early child vaccination [52,63,64]. On the other hand, mothers with no education as well as those who are unemployed are less likely to vaccinate their children [65,66,67]. The present study confirmed that mothers with higher educational achievement are less likely to have zero-dose children compared to mothers with no education.
Previous studies have reported that birthweight is an important predictor of childhood vaccination in SSA. O’Leary et al. found that LBW children in Ghana were less likely to receive BCG immunization [68,69]. Their study further indicates that regardless of birthplace, vaccination declines with decreasing birth weight [68]. Similarly, research of Roth et al. conducted in Guinea-Bissau, found that children with LBW were twice as likely to be unvaccinated than those with normal birth weight [70]. The present study confirms that children with normal birthweight were less likely to have zero-dose vaccination status compared to children who were not weighed at birth. Nevertheless, fourth to fifth born children were less likely to have zero-dose vaccination status compared to first born children. This has been reported in a similar study [23].
For more than two decades, scientists, epidemiologists and other stakeholders in the healthcare sector have observed that imbalance in wealth index remains a challenge in delivering healthcare services in SSA [63,71]. Consequently, this study confirms that most households fall within the poorest and poorer categories of wealth index. Households in the middle, richer and richest wealth quintiles are predominantly located in urban areas and likely to have access to good health care facilities. Notably, the wealth index may have a social influence; children from richer households appear to have higher odds of receiving early vaccination than children from poor households, who mainly dominate the zero-dose group. Surprisingly, this study confirms that certain countries with high GDP per capita are four times more likely to have zero-dose children compared to countries with low GDP per capita. This could pertain to the relative wealth index within each country [72]. As such, countries with large revenues from natural resources could appear better off than others even when few people earn sizeable incomes [72]. For instance, Nigeria, with a high GDP per capita, has the highest number of zero-dose children [28]. The number of zero-dose children in countries with high GDP per capita could be attributed to population size, government regulation and unfair health policies.
In light of recent goals set by the Immunization Agenda 2030 (IA2030), including reducing the number of zero-dose children by half, research that goes beyond coverage to identify populations and groups of children at greater risk of being unvaccinated is urgently needed. While much work remains, our results can begin to inform efforts to identify and reach children who have not received any vaccines. Our data suggest that mother’s education, employment, and receipt of antenatal healthcare services may serve as useful indicators in screening tools developed to proactively identify children at risk of being unvaccinated. Screening tools might also incorporate an abbreviated asset index, such as the EquityTool [73], as lower household wealth is strongly associated with zero-dose vaccination status. Our findings also suggest that the number of zero-dose children may be reduced by increasing access to antenatal healthcare services or by educating girls and women. More work is needed to evaluate the effects of specific interventions, including targeted healthcare campaigns and awareness creation. Additional work employing geospatial analysis and modeling strategies could be applied to address issues surrounding zero-dose children and ultimately improve the health and future of children in SSA [25,31,57].
The following limitations of this study are worth noting. First, this study relied on a secondary analysis of publicly available survey data, which might have impacted the findings. Second, survey years and the timing of national measures differ across the countries. To address this, we included birth year as a partial control for common trends over the sample period and to adjust for effects of unobserved temporal factors. Third, given the cross-sectional nature of the data, this study cannot establish causality. However, using nationally representative data from 33 country in SSA, findings from this study is robust and can be used for policy intervention in SSA. It can also help push towards attaining the IA2030 and SDGs agenda. Fourth, to assess the association between zero-dose children and the explanatory variables, the current study utilized multi-level models. Despite the statistical significance of these variables, these models may affect the generalization of the findings presented in our study. Hence, further studies are required to validate the findings presented in the current study.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vaccines10071052/s1, Table S1: Multi-level analysis of factors associated with zero-dose vaccination status among children aged 12–59 months in SSA.

Author Contributions

Conceptualization C.E.O., N.L.H. and B.O.; Database preparation: C.E.O. and N.L.H.; Methodology: C.E.O., N.L.H., B.O., Z.L. and J.W.H.; First analysis: C.E.O. and N.L.H.; Data interpretation: C.E.O., N.L.H., B.O., Z.L. and J.W.H.; First draft: C.E.O. and N.L.H.; Critical manuscript revision: C.E.O., N.L.H., B.O., Z.L. and J.W.H. All authors have read and agreed to the published version of the manuscript.

Funding

This work was partially supported by a SPARC Graduate Research Grant from the Office of the Vice President for Research at the University of South Carolina.

Institutional Review Board Statement

The organizations who administered the surveys were responsible for ethical clearance according to the norms of each country.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the surveys.

Data Availability Statement

All the analyses were carried out using publicly available datasets that can be obtained directly from the DHS (https://dhsprogram.com/) (accessed 16 April 2022), World Bank (https://www.worldbank.org/) (accessed 16 April 2022), and Vision of Humanity (https://www.visionofhumanity.org/maps/#/) (accessed 16 April 2022) websites.

Acknowledgments

The Demographic and Health Surveys program are appreciated for granting access to use the data for this research.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Maman, K.; Zöllner, Y.; Greco, D.; Duru, G.; Sendyona, S.; Remy, V. The value of childhood combination vaccines: From beliefs to evidence. Hum. Vaccines Immunother. 2015, 11, 2132–2141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Kc, A.; Nelin, V.; Raaijmakers, H.; Kim, H.J.; Singh, C.; Målqvist, M. Increased immunization coverage addresses the equity gap in Nepal. Bull. World Health Organ. 2017, 95, 261–269. [Google Scholar] [CrossRef] [PubMed]
  3. WHO Global Routine Immunization Strategies and Practices (GRISP): A Companion Document to the Global Vaccine Action Plan. (GVAP). 2016. Available online: http://apps.who.int/iris/bitstream/10665/204500/1/9789241510103_eng.pdf (accessed on 15 March 2021).
  4. Kretsinger, K.; Gasasira, A.; Poy, A.; Porter, K.A.; Everts, J.; Salla, M.; Brown, K.H.; Wassilak, S.G.F.; Nshimirimana, D. Polio Eradication in the World Health Organization African Region, 2008–2012. J. Infect. Dis. 2014, 210 (Suppl. 1), 23–29. [Google Scholar] [CrossRef] [Green Version]
  5. Waziri, N.E.; Ohuabunwo, C.J.; Nguku, P.M.; Ogbuanu, I.U.; Gidado, S.; Biya, O.; Wiesen, E.S.; Vertefeuille, J.; Townes, D.; Oyemakinde, A.; et al. Polio eradication in Nigeria and the role of the national stop transmission of polio program, 2012–2013. J. Infect. Dis. 2014, 210 (Suppl. 1), S111–S117. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. WHO. The Measles & Rubella Initiative Welcomes World Health Assembly Commitment to Measles and Rubella Elimination Goals. Available online: https://www.who.int/immunization/newsroom/measles_rubella_wha_elimination_goals_statement_may12/en/ (accessed on 15 March 2020).
  7. Brownwright, T.K.; Dodson, Z.M.; Van Panhuis, W.G. Spatial clustering of measles vaccination coverage among children in sub-Saharan Africa. BMC Public Health 2017, 17, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Wobudeya, E.; Lukoye, D.; Lubega, I.R.; Mugabe, F.; Sekadde, M.; Musoke, P. Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009–2010; a retrospective cross-sectional study. BMC Public Health 2015, 15, 1–8. [Google Scholar] [CrossRef] [Green Version]
  9. Antai, D. Inequitable childhood immunization uptake in Nigeria: A multilevel analysis of individual and contextual determinants. BMC Infect. Dis. 2009, 9, 181. [Google Scholar] [CrossRef] [Green Version]
  10. Wiysonge, C.S.; Uthman, O.A.; Ndumbe, P.M.; Hussey, G.D. Individual and contextual factors associated with low childhood immunisation coverage in Sub-Saharan Africa: A multilevel analysis. PLoS ONE 2012, 7, e37905. [Google Scholar] [CrossRef] [Green Version]
  11. WHO. 1 in 5 Children in Africa Do Not Have Access to Life-Saving Vaccines. WHO|Regional Office for Africa. Available online: https://www.afro.who.int/news/1-5-children-africa-do-not-have-access-life-saving-vaccines (accessed on 29 August 2020).
  12. WHO|Regional Office for Africa. Immunization. Available online: https://www.afro.who.int/health-topics/immunization (accessed on 24 June 2022).
  13. WHO. Reaching Every District (RED) Approach: A Way to Improve Immunization Performance. Available online: https://www.who.int/bulletin/volumes/86/3/07-042127/en/ (accessed on 19 November 2021).
  14. WHO. Global Immunization Vision and Strategy 2006–2015. Available online: https://apps.who.int/iris/bitstream/handle/10665/69146/WHO_IVB_05.05.pdf;jsessionid=8C20744530CE6D2D34CAD14342C0166C?sequence=1 (accessed on 17 October 2019).
  15. WHO. Global Vaccine Action Plan 2011–2020. WHO. Available online: http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/ (accessed on 19 March 2021).
  16. Ikilezi, G.E.; Micah, A.; Bachmeier, S.D.E.; Cogswell, I.; Maddison, E.R.; Stutzman, H.N.; Tsakalos, G.; Brenzel, L.; Dieleman, J.L. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000–2017: A financial modelling study. Lancet 2021, 398, 1875–1893. [Google Scholar] [CrossRef]
  17. UNICEF Immunization Data. UNICEF DATA. Available online: https://data.unicef.org/topic/child-health/immunization/ (accessed on 29 September 2021).
  18. UNICEF. Vaccination and Immunization Statistics. UNICEF DATA. Available online: https://data.unicef.org/topic/child-health/immunization/ (accessed on 4 February 2022).
  19. WHO-UNICEF Coverage Estimates WHO World Health Organization: Immunization, Vaccines and Biologicals. Vaccine Preventable Diseases Vaccines Monitoring System 2018 Global Summary Reference Time Series: DTP3. Available online: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html (accessed on 1 October 2020).
  20. WHO. Childhood Vaccination in Africa and Asia: The Effects of Parents’ Knowledge and Attitudes. Available online: https://www.who.int/bulletin/volumes/86/6/07-047159/en/ (accessed on 20 January 2021).
  21. WHO. Implementing the Immunization Agenda 2030: A Framework for Action through Coordinated Planning, Monitoring & Evaluation, Ownership & Accountability, and Communications & Advocacy. 2020. Available online: https://cdn.who.int/media/docs/default-source/immunization/strategy/ia2030/ia2030_frameworkforactionv04.pdf?sfvrsn=e5374082_1&download=true (accessed on 4 February 2022).
  22. UNDP. Sustainable Development Goals|United Nations Development Programme. Available online: https://www.undp.org/sustainable-development-goals (accessed on 5 February 2022).
  23. Chido-Amajuoyi, O.G.; Wonodi, C.; Mantey, D.; Perez, A.; McAlister, A. Prevalence and correlates of never vaccinated Nigerian children, aged 1–5 years. Vaccine 2018, 36, 6953–6960. [Google Scholar] [CrossRef]
  24. Cata-Preta, B.O.; Santos, T.M.; Mengistu, T.; Hogan, D.R.; Barros, A.J.; Victora, C.G. Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries. Vaccine 2021, 39, 4564–4570. [Google Scholar] [CrossRef] [PubMed]
  25. Arambepola, R.; Yang, Y.; Hutchinson, K.; Mwansa, F.D.; Doherty, J.A.; Bwalya, F.; Ndubani, P.; Musukwa, G.; Moss, W.J.; Wesolowski, A.; et al. Using geospatial models to map zero-dose children: Factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia. BMJ Glob. Health 2021, 6, e007479. [Google Scholar] [CrossRef]
  26. Galles, N.C.; Liu, P.Y.; Updike, R.L.; Fullman, N.; Nguyen, J.; Rolfe, S.; Sbarra, A.N.; Schipp, M.F.; Marks, A.; Abady, G.G.; et al. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: A systematic analysis for the Global Burden of Disease Study 2020, Release 1. Lancet 2021, 398, 503–521. [Google Scholar] [CrossRef]
  27. Murhekar, M.V.; Kumar, M.S. Reaching zero-dose children in India: Progress and challenges ahead. Lancet Glob. Health 2021, 9, e1630–e1631. [Google Scholar] [CrossRef]
  28. Johri, M.; Rajpal, S.; Subramanian, S.V. Progress in reaching unvaccinated (zero-dose) children in India, 1992–2016: A multilevel, geospatial analysis of repeated cross-sectional surveys. Lancet Glob. Health 2021, 9, e1697–e1706. [Google Scholar] [CrossRef]
  29. Vanderende, K.; Gacic-Dobo, M.; Diallo, M.; Conklin, L.M.; Wallace, A.S. Global routine vaccination coverage—2017. Morb. Mortal. Wkly. Rep. 2018, 67, 1261–1264. [Google Scholar] [CrossRef] [Green Version]
  30. Bosch-Capblanch, X.; Banerjee, K.; Burton, A. Unvaccinated children in years of increasing coverage: How many and who are they? Evidence from 96 low- and middle-income countries. Trop. Med. Int. Health 2012, 17, 697–710. [Google Scholar] [CrossRef] [Green Version]
  31. Bobo, F.T.; Asante, A.; Woldie, M.; Dawson, A.; Hayen, A. Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities. Vaccine 2022, 40, 141–150. [Google Scholar] [CrossRef]
  32. The DHS Program—Quality Information to Plan, Monitor and Improve Population, Health, and Nutrition Programs. Available online: https://dhsprogram.com/ (accessed on 16 April 2022).
  33. The DHS Program—Demographic and Health Survey (DHS). Available online: https://dhsprogram.com/What-We-Do/Survey-Types/DHS.cfm (accessed on 27 September 2020).
  34. The DHS Program—Team and Partners. Available online: https://dhsprogram.com/Who-We-Are/About-Us.cfm (accessed on 27 September 2020).
  35. Croft, T.N.; Marshall, A.M.J.; Allen, C.K. Guide to DHS Statistics; ICF: Rockville, MD, USA, 2018; Available online: https://dhsprogram.com/Data/Guide-to-DHS-Statistics/index.cfm (accessed on 27 September 2020).
  36. Corsi, D.J.; Neuman, M.; Finlay, J.E.; Subramanian, S.V. Demographic and health surveys: A profile. Int. J. Epidemiol. 2012, 41, 1602–1613. [Google Scholar] [CrossRef]
  37. World Bank Group—International Development, Poverty, & Sustainability; World Bank: Washington, DC, USA; Available online: https://www.worldbank.org/en/home (accessed on 16 April 2022).
  38. Global Peace Index Map » The Most & Least Peaceful Countries. Vision of Humanity. Available online: https://www.visionofhumanity.org/maps/ (accessed on 16 April 2022).
  39. Ren, R. Note on de-Normalization of DHS Standard Weight. The DHS Program User Forum: Weighting data, Question Re-Weighting Combined Survey Data. Available online: https://userforum.dhsprogram.com/index.php?t=msg&goto=81&S=Google (accessed on 28 November 2021).
  40. United Nations. Department of Economic and Social Affairs Population Dynamics: World Population Prospects. Available online: https://population-un-org.pallas2.tcl.sc.edu/wpp/Download/Standard/Population/ (accessed on 28 November 2021).
  41. Midi, H.; Sarkar, S.; Rana, S. Collinearity diagnostics of binary logistic regression model. J. Interdiscip. Math. 2010, 13, 253–267. [Google Scholar] [CrossRef]
  42. Merlo, J.; Chaix, B.; Yang, M.; Lynch, J.; Råstam, L. A brief conceptual tutorial of multilevel analysis in social epidemiology: Linking the statistical concept of clustering to the idea of contextual phenomenon. J. Epidemiol. Commun. Health 2005, 59, 443–449. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Merlo, J.; Yang, M.; Chaix, B.; Lynch, J.; Råstam, L. A brief conceptual tutorial on multilevel analysis in social epidemiology: Investigating contextual phenomena in different groups of people. J. Epidemiol. Commun. Health 2005, 59, 729–736. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Merlo, J.; Chaix, B.; Ohlsson, H.; Beckman, A.; Johnell, K.; Hjerpe, P.; Råstam, L.; Larsen, K. A brief conceptual tutorial of multilevel analysis in social epidemiology: Using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J. Epidemiol. Commun. Health 2006, 60, 290–297. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Larsen, K. Appropriate Assessment of Neighborhood Effects on Individual Health: Integrating Random and Fixed Effects in Multilevel Logistic Regression. Am. J. Epidemiol. 2005, 161, 81–88. [Google Scholar] [CrossRef]
  46. Austin, P.C.; Merlo, J. Intermediate and advanced topics in multilevel logistic regression analysis. Stat. Med. 2017, 36, 3257–3277. [Google Scholar] [CrossRef]
  47. De Vaus, D. Analyzing Social Science Data: 50 Key Problems in Data Analysis; SAGE: Los Angeles, CA, USA, 2002. [Google Scholar]
  48. Chard, A.N.; Gacic-Dobo, M.; Diallo, M.S.; Sodha, S.V.; Wallace, A.S. Routine Vaccination Coverage—Worldwide, 2019. Morb. Mortal. Wkly. Rep. 2020, 69, 1706–1710. [Google Scholar] [CrossRef]
  49. Burch, A. Progress and Challenges with Achieving Universal Immunization Coverage. 2020, p. 22. Available online: https://www.who.int/publications/m/item/progress-and-challenges-with-achievinguniversal-immunization-coverage (accessed on 5 February 2022).
  50. Malhame, M.; Baker, E.; Gandhi, G.; Jones, A.; Kalpaxis, P.; Iqbal, R.; Momeni, Y.; Nguyen, A. Shaping markets to benefit global health—A 15-year history and lessons learned from the pentavalent vaccine market. Vaccine: X 2019, 2, 100033. [Google Scholar] [CrossRef]
  51. Gavi. Zero-Dose Children and Missed Communities. Available online: https://www.gavi.org/our-alliance/strategy/phase-5-2021-2025/equity-goal/zero-dose-children-missed-communities (accessed on 5 February 2022).
  52. Tesema, G.A.; Tessema, Z.T.; Tamirat, K.S.; Teshale, A.B. Complete basic childhood vaccination and associated factors among children aged 12–23 months in East Africa: A multilevel analysis of recent demographic and health surveys. BMC Public Health 2020, 20, 1–14. [Google Scholar] [CrossRef]
  53. Janusz, C.B.; Frye, M.; Mutua, M.K.; Wagner, A.L.; Banerjee, M.; Boulton, M.L. Vaccine delay and its association with undervaccination in children in Sub-Saharan Africa. Am. J. Prev. Med. 2020, 60, S53–S64. [Google Scholar] [CrossRef]
  54. Causey, K.; Fullman, N.; Sorensen, R.J.D.; Galles, N.C.; Zheng, P.; Aravkin, A.; Danovaro-Holliday, M.C.; Martinez-Piedra, R.; Sodha, S.V.; Velandia-González, M.P.; et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: A modelling study. Lancet 2021, 398, 522–534. [Google Scholar] [CrossRef]
  55. Grundy, J.; Biggs, B.-A. The Impact of conflict on immunisation coverage in 16 countries. Int. J. Health Policy Manag. 2018, 8, 211–221. [Google Scholar] [CrossRef] [Green Version]
  56. Sato, R. Effect of armed conflict on vaccination: Evidence from the Boko haram insurgency in northeastern Nigeria. Confl. Health 2019, 13, 1–10. [Google Scholar] [CrossRef] [PubMed]
  57. Stoop, N.; Hirvonen, K.; Maystadt, J.-F. Institutional mistrust and child vaccination coverage in Africa. BMJ Glob. Health 2021, 6, e004595. [Google Scholar] [CrossRef] [PubMed]
  58. Jani, J.V.; De Schacht, C.; Jani, I.V.; Bjune, G. Risk factors for incomplete vaccination and missed opportunity for immunization in rural Mozambique. BMC Public Health 2008, 8, 161–167. [Google Scholar] [CrossRef] [Green Version]
  59. Abdulraheem, I.S.; Onajole, A.T.; Jimoh, A.A.G.; Oladipo, A.R. Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children. J. Public Health Epidemiol. 2011, 3, 194–203. [Google Scholar] [CrossRef]
  60. Laryea, D.O.; Parbie, E.A.; Frimpong, E. Timeliness of childhood vaccine uptake among children attending a tertiary health service facility-based immunisation clinic in Ghana. BMC Public Health 2014, 14, 90. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Sarker, A.R.; Akram, R.; Ali, N.; Chowdhury, Z.I.; Sultana, M. Coverage and determinants of full immunization: Vaccination coverage among Senegalese children. Medicina 2019, 55, 480. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Noh, J.-W.; Kim, Y.M.; Akram, N.; Yoo, K.-B.; Park, J.; Cheon, J.; Kwon, Y.D.; Stekelenburg, J. Factors affecting complete and timely childhood immunization coverage in Sindh, Pakistan; A secondary analysis of cross-sectional survey data. PLoS ONE 2018, 13, e0206766. [Google Scholar] [CrossRef] [PubMed]
  63. Oleribe, O.; Kumar, V.; Awosika-Olumo, A.; Taylor, S.D. Individual and socioeconomic factors associated with childhood immunization coverage in Nigeria. Pan Afr. Med. J. 2017, 26, 220. [Google Scholar] [CrossRef]
  64. Feyisetan, B.J.; Asa, S.; Ebigbola, J.A. Mothers’ management of childhood diseases in Yorubaland: The influence of cultural beliefs. Health Transit. Rev. Cult. Social. Behav. Determ. Health 1997, 7, 221–234. [Google Scholar]
  65. Streatfield, K.; Singarimbun, M.; Diamond, I. Maternal education and child immunization. Demography 1990, 27, 447–455. [Google Scholar] [CrossRef] [PubMed]
  66. Burroway, R.; Hargrove, A. Education is the antidote: Individual- and community-level effects of maternal education on child immunizations in Nigeria. Soc. Sci. Med. 2018, 213, 63–71. [Google Scholar] [CrossRef] [PubMed]
  67. Özer, M.; Fidrmuc, J.; Eryurt, M.A. Maternal education and childhood immunization in Turkey. Health Econ. 2018, 27, 1218–1229. [Google Scholar] [CrossRef] [PubMed]
  68. O’Leary, M.; Thomas, S.; Hurt, L.; Floyd, S.; Shannon, C.; Newton, S.; Thomas, G.; Amenga-Etego, S.; Tawiah-Agyemang, C.; Gram, L.; et al. Vaccination timing of low-birth-weight infants in rural Ghana: A population-based, prospective cohort study. Bull. World Health Organ. 2016, 94, 442–451. [Google Scholar] [CrossRef]
  69. O’Leary, M.; Edmond, K.; Floyd, S.; Hurt, L.; Shannon, C.; Thomas, G.; Newton, S.; Kirkwood, B.; Thomas, S. Neonatal vaccination of low birthweight infants in Ghana. Arch. Dis. Child. 2017, 102, 145–151. [Google Scholar] [CrossRef]
  70. Roth, A.; Jensen, H.; Garly, M.-L.; Djana, Q.; Martins, C.L.; Sodemann, M.; Rodrigues, A.; Aaby, P. Low birth weight infants and calmette-guérin bacillus vaccination at birth. Pediatr. Infect. Dis. J. 2004, 23, 544–550. [Google Scholar] [CrossRef]
  71. Geweniger, A.; Abbas, K.M. Childhood vaccination coverage and equity impact in Ethiopia by socioeconomic, geographic, maternal, and child characteristics. Vaccine 2020, 38, 3627–3638. [Google Scholar] [CrossRef]
  72. Rutstein, S.O.; Staveteig, S. Making the Demographic and Health Surveys Wealth Index Comparable; ICF International: Rockville, MD, USA, 2014. [Google Scholar]
  73. Home. Equity Tool. Available online: https://www.equitytool.org/ (accessed on 24 June 2022).
Figure 1. Multi-level analysis of individual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA. Estimates from Model 4 (Table S1). X-axis presented on natural log scale.
Figure 1. Multi-level analysis of individual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA. Estimates from Model 4 (Table S1). X-axis presented on natural log scale.
Vaccines 10 01052 g001
Figure 2. Multi-level analysis of contextual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA. Estimates from Model 4 (Table S1). X-axis presented on natural log scale.
Figure 2. Multi-level analysis of contextual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA. Estimates from Model 4 (Table S1). X-axis presented on natural log scale.
Vaccines 10 01052 g002
Table 1. Summary of eligible SSA countries and the DHS survey features.
Table 1. Summary of eligible SSA countries and the DHS survey features.
CountrySurvey YearSample Size (Weighted)
Angola2015–20161458
Burkina Faso20101618
Benin2017–20181403
Burundi2016–2017622
Congo DRC2013–20145336
Congo2011–20121882
Cote d’Ivore2011–2012767
Cameroun2018482
Ethiopia20162407
Gabon2012726
Ghana2014396
Gambia2019–2020101
Guinea2018471
Kenya20142219
Comoros2012866
Liberia2019–2020345
Lesotho2014210
Mali20181769
Malawi2015–2016515
Mozambique20111703
Nigeria20182670
Niger20122338
Namibia2013375
Rwanda2014–2015250
Sierra Leone2019416
Senegal2010–20111557
Chad2014–20156712
Togo2013–20141013
Tanzania2015–2016635
Uganda2016557
South Africa2016128
Zambia2018853
Zimbabwe2015331
Total 43,131
Table 2. Baseline characteristics and bivariate analysis of individual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA (N = 43,131).
Table 2. Baseline characteristics and bivariate analysis of individual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA (N = 43,131).
CharacteristicsUnivariateBivariate
n%Zero-DoseVaccinatedp-Value
n%n%
    Vaccinated35,92083.5
    Zero-dose721116.5
Child’s sex
    Male21,68450.7360116.418,08383.60.6898
    Female21,44749.3361016.717,83783.3
Child’s age (months)
    12–2412,88435.7254220.110,34279.9<0.0001
    25–3614,83638.7261317.812,22382.2
    37–48803413.310489.8698690.2
    49–59737712.410089.4636990.6
Birth order
    1793018117715.0675385.00.0316
    2–314,26232.7234315.911,91984.1
    4–510,47024188016.7859083.3
    6+10,46925.4181118.2865881.8
Birth weight
    Low BW17333.71409.1159391<0.0001
    Normal BW12,38926.47135.311,67694.7
    High BW3,4278.42026.0322594.0
    Not weighed25,58260.5615623.519,42676.5
Mother’s age (years)
    15–1921674.444921.8171878.20.0135
    20–24925421154617.7770882.3
    25–3421,04850.5346915.617,57984.4
    35–39654514.9104716.1549883.9
    40–4430737.050216.6257183.4
    45–4910442.219817.484682.6
Mother’s marital status
    Single/Widowed47229.958612.8413687.20.0005
    Married/Co-habiting38,40990.1662516.931,78483.1
Mother’s educational level
    No education22,11547.6528023.716,83576.3<0.0001
    Primary school12,46830.8135112.411,11787.6
    Incomplete high school620413.64507.0575493.0
    Completed high school23448.01305.49221494.5
Mother’s occupation
    Unemployed18,58043.3398221.114,59878.9<0.0001
    Employed24,55156.7322913.021,32287.0
Antenatal visit
    No visit670318.1275035.9395364.1<0.0001
    <4 visits820620.191313.3729386.7
    4 or more visits11,97228.88878.9711,08591.0
    Not asked 116,25033266114.513,58985.5
Place of child’s delivery
    Home20,52248.6539924.615,12375.4<0.0001
    Public hospital18,98040.313237.7617,65792.2
    Private hospital24317.71616.34227093.7
    Other 11983.432828.087072.0
Exposure to Media
    No TV/Radio20,49750.7418820.216,30979.8<0.0001
    Has TV/Radio22,63449.3302312.719,61187.3
1 Question not asked in DHS Survey. Questions regarding the number of antenatal care visits were asked in reference to a woman’s most recent pregnancy (youngest child) only.
Table 3. Baseline characteristics and bivariate analysis of contextual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA (N = 43,131).
Table 3. Baseline characteristics and bivariate analysis of contextual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA (N = 43,131).
CharacteristicsUnivariateBivariate
n%Zero-DoseVaccinatedp-Value
n%n%
    Vaccinated35,92083.5
    Zero-dose721116.5
Place of residence
    Urban11,22325.012238.6710,00091.3<0.0001
    Rural31,90875.0598819.125,92080.9
Wealth index
    Poorest12,90226.3277823.510,12476.5<0.0001
    Poorer943023.1172620.3770479.7
    Middle803920.0127014.8676985.2
    Richer718517.497610.4620989.6
    Richest557513.24616.59511493.4
Religion
    Christian20,33955.4232912.318,01087.7<0.0001
    Islam16,18131.6396625.212,21574.8
    Others22312.826415.0196785.0
    No religion12221.924018.798281.3
    Not asked 1 31588.341211.1274688.9
GDP per capita 2
    Low16,54054.7212015.214,42084.8<0.0001
    Moderate14,86720.2306015.311,80784.7
    High11,72425.1203120.4969379.6
Health expenditure 2
    Low28,31776.2536117.622,95682.4<0.0001
    High14,81423.8185013.112,96486.9
Literacy rate 2
    Low26,05761.3574021.920,31778.1<0.0001
    High17,07438.714717.9415,60392.1
Unemployment rate 2
    Low27,59670.8475315.622,84384.40.0002
    High15,53529.2245818.813,07781.2
Fertility rate 2
    Low17,77640.2249218.615,28481.40.0001
    High25,35559.8471915.120,63684.9
Physician density 2
    Low19,31541.6378520.415,53079.6<0.0001
    Moderate12,32331.214499.5110,87490.5
    High11,49327.2197718.6951681.4
Global Peace Index 3
    Low10,76515.8130813.1945786.9<0.0001
    Moderate15,77739.6290521.112,87278.9
    High16,58944.5299813.613,59186.4
UN African Sub-region
    Western Africa14,86431.1248418.212,38081.8<0.0001
    Eastern Africa10,95835.4169120926780.0
    Middle Africa16,59632.2299711.413,59988.6
    Southern Africa7131.4398.667491.4
1 Question not asked in DHS Survey. Data unavailable for South Africa, Tanzania, and Niger. 2 National measures of GDP per capita, domestic general government health expenditure as a percentage of general government expenditure, adult female literacy rate, female unemployment rate, fertility rate, physicians per 1000 people were obtained from the World Bank [37]. 3 National measures of the Global Peace Index (GPI) overall score were obtained from the Institute for Economics and Peace (IEP). The GPI is a composite index measuring the peacefulness of countries. The lower the score the more peaceful the country [38].
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ozigbu, C.E.; Olatosi, B.; Li, Z.; Hardin, J.W.; Hair, N.L. Correlates of Zero-Dose Vaccination Status among Children Aged 12–59 Months in Sub-Saharan Africa: A Multilevel Analysis of Individual and Contextual Factors. Vaccines 2022, 10, 1052. https://doi.org/10.3390/vaccines10071052

AMA Style

Ozigbu CE, Olatosi B, Li Z, Hardin JW, Hair NL. Correlates of Zero-Dose Vaccination Status among Children Aged 12–59 Months in Sub-Saharan Africa: A Multilevel Analysis of Individual and Contextual Factors. Vaccines. 2022; 10(7):1052. https://doi.org/10.3390/vaccines10071052

Chicago/Turabian Style

Ozigbu, Chamberline E., Bankole Olatosi, Zhenlong Li, James W. Hardin, and Nicole L. Hair. 2022. "Correlates of Zero-Dose Vaccination Status among Children Aged 12–59 Months in Sub-Saharan Africa: A Multilevel Analysis of Individual and Contextual Factors" Vaccines 10, no. 7: 1052. https://doi.org/10.3390/vaccines10071052

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop